Onyx Pharma dealmakers build M&A culture

When Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) bought Proteolix Inc. on Oct. 12, (The Deal Pipeline subscription required) it was the first-ever acquisition for the 17-year-old Emeryville, Calif. firm. And in an industry underpinned by licensing deals, Onyx has only signed two, both coming in 2008. Rather than look outside for growth, Onyx has been developing Nexavar, a drug approved in more than...